Welcome to our dedicated page for Life360 SEC filings (Ticker: LIF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Life360, Inc. filings document regulatory disclosures for a Delaware technology company whose common stock trades on Nasdaq under LIF. Form 8-K reports furnish operating and financial results, Regulation FD presentation materials, material-event disclosures, material agreements, shareholder voting matters and capital-structure information.
Proxy materials describe board and executive compensation matters, equity awards, corporate governance and voting procedures. The filing record also reflects disclosure areas tied to Life360’s family safety platform, subscription metrics, advertising initiatives, legal and compliance oversight, and public-company securities reporting.
Life360, Inc. director David Wiadrowski reported an option exercise and related share sale. On March 13, 2026, he exercised stock options for 21,310 shares of common stock, including 13,850 shares at an exercise price of $13.35 and 7,460 shares at $8.19 per share.
The filing shows an open-market sale of 5,957 shares of common stock at a weighted average price of $41.34 per share, with footnotes stating these shares were sold solely to cover the option exercise cost. After these transactions, he directly owned 39,679 shares of common stock, which includes 738 restricted stock units that will convert into shares upon vesting.
Life360, Inc. director Charles J. Prober reported an exercise-and-sell transaction involving 7,930 shares. On 2026-03-13, he exercised stock options to acquire 7,930 shares of common stock at an exercise price of $11.18 per share, then sold 7,930 shares of common stock at $41.40 per share in an open-market transaction.
The activity was carried out under a pre-arranged Rule 10b5-1 trading plan adopted on 2025-03-14. After these transactions, Prober directly held 105,456 shares of common stock, including 679 restricted stock units that each represent a right to receive one share upon vesting.
Filer submitted a Form 144 reporting the proposed sale of 5,957 common shares. The filing lists proposed sales dated 03/13/2026 tied to options granted on 04/29/2021 (4,479 shares) and 05/20/2022 (1,478 shares), with proceeds described as cash.
The notice names Fidelity Brokerage Services LLC as the broker for the transactions and lists NASDAQ as the exchange. The filing records proposed sale activity under Regulation 144 procedures on 03/13/2026.
LIF filed a Rule 144 notice reporting sales of Common Stock by Charles Prober. The filing lists multiple sale dates and dollar amounts, including 12/15/2025 ($541,619.00), 01/13/2026 ($491,501.40) and 02/13/2026 ($388,728.60). The filing also references a 03/13/2026 entry and broker information for Fidelity Brokerage Services LLC.
Life360 director John Philip Coghlan, through the John Coghlan Living Trust, reported open-market sales of 4,000 shares of common stock on March 9, 2026. The shares were sold in two trades at weighted average prices of $45.29 and $46.56 per share.
The sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 8, 2025, meaning they were scheduled in advance. After these transactions, the trust held 5,065 shares, while Coghlan also held 36,202 shares directly and 55,494 shares indirectly through a separate grantor retained annuity trust, including 836 restricted stock units.
Life360, Inc. Chief Financial Officer Russell John Burke reported a routine equity compensation event. On the vesting and net settlement of previously granted restricted stock units, 5,800 shares of common stock were withheld by the company to satisfy income tax withholding and remittance obligations, and this is explicitly not a sale by the executive.
Following this tax-withholding disposition, Burke holds 78,857 shares of common stock directly and 91,077 shares indirectly through the Russell John Burke Revocable Trust. These indirect holdings include 56,573 restricted stock units, each representing a contingent right to receive one share of Life360 common stock upon vesting.
Life360, Inc. director Chris Hulls reported a routine tax-related share disposition. On March 6, 2026, 5,248 shares of common stock were withheld by the company at $44.91 per share to satisfy income tax obligations tied to vesting restricted stock units, and were not sold in the open market. After this withholding, Hulls held 322,452 shares directly, a figure that includes common stock, shares underlying Chess Depositary Interests, and 108,371 unvested restricted stock units. The filing also shows indirect holdings of 195,312 shares each in three separate 2023 irrevocable trusts.
Life360, Inc. Chief Executive Officer Lauren Antonoff sold 17,153 shares of common stock at $44.86 per share. According to the disclosure, this was a sell-to-cover transaction to satisfy tax withholding obligations from vesting RSUs, not a discretionary sale. After the sale, Antonoff directly held 288,232 shares and had 143,367 RSUs outstanding.
Life360, Inc. director John Philip Coghlan exercised a stock option and acquired 31,938 shares of common stock at $0.18 per share through a derivative exercise on March 5, 2026. After this transaction, he directly holds 36,202 shares of common stock, which includes 1,672 restricted stock units that each represent a contingent right to receive one share upon vesting.
He also has indirect ownership of common stock, with 9,065 shares held by the John Coghlan Living Trust and 55,494 shares held by The John Philip Coghlan 2025 Grantor Retained Annuity Trust. The reported numbers were adjusted because a previously reported transfer of 1,672 directly held shares to the living trust has not yet occurred.